adalimumab

A1D2A1L1I1M3U1M3A1B3
US/ˌeɪ.dəˈlɪm.jəˌmæb/

noun

An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.

RareScrabble 17

Meanings

nounadalimumab (uncountable)
  1. uncountablemedicineAn immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.

Origin

From ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).

Full word history & related roots →

Translations

Finnish adalimumabi
  • adalimumabimonoclonal antibody
Cite this entry
APA

adalimumab. (n.d.). In WatkinsX Dictionary. Retrieved November 3, 2026, from https://dictionary.watkinsx.com/word/adalimumab

MLA

“adalimumab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/adalimumab. Accessed November 3, 2026.

Chicago

WatkinsX Dictionary, s.v. “adalimumab,” accessed November 3, 2026, https://dictionary.watkinsx.com/word/adalimumab.

Source: adalimumab on Wiktionary, CC BY-SA 4.0.